<i>Dobbs</i> and the Destabilization of Clinical Trials

This Article explores an important yet overlooked collateral consequence of the U.S. Supreme Court's elimination of the constitutional right to abortion in Dobbs v. Jackson Women's Health Organization: the destabilization of clinical research. Specifically, this Article focuses on the harms to pregnant persons, persons capable of pregnancy, and persons of color that may transpire as a result of new barriers to clinical research in the aftermath of Dobbs. By hindering clinical research, these new obstacles will exacerbate existing health disparities experienced by these populations, which have historically been excluded from or exploited by the American healthcare and research systems.\nThis Article provides an in-depth legal analysis of the anti-abortion movement's new post-Dobbs strategies and how they may fetter clinical research that provides essential knowledge about the effects of medical products on pregnant persons and fetuses. Critically, this Article makes clear that Dobbs was not the anti-abortion movement's endgame. On the contrary, the anti-abortion movement has continued to mobilize post-Dobbs in pursuit of new legal strategies, including attacking the federal approval of mifepristone, reinvigorating the Comstock Act, and establishing fetal-personhood laws. In the context of clinical research, these post-Dobbs strategies will not only dilute medical knowledge and undermine scientific integrity they will also disproportionately affect populations already afflicted by glaring health disparities. After cataloging the various ways in which the anti-abortion movement's strategies will destabilize clinical research, this Article concludes with strategies to combat these pernicious results. Importantly, although this Article focuses on clinical research, it illustrates a broader consequence of the anti-abortion movement's new strategies: the aggravation of sex, gender, and racial disparities, which must be responded to with comprehensive counterstrategies

Publication Details

Journal
eYLS (Yale Law School)
Published
2024-10-01
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dobbs and the Destabilization of Clinical Trials

eYLS (Yale Law School)
Reproductive Health and Contraception
article

Dobbs and the Destabilization of Clinical Trials

article en

Abstract

This Article explores an important yet overlooked collateral consequence of the U.S. Supreme Court's elimination of the constitutional right to abortion in Dobbs v. Jackson Women's Health Organization: the destabilization of clinical research. Specifically, this Article focuses on the harms to pregnant persons, persons capable of pregnancy, and persons of color that may transpire as a result of new barriers to clinical research in the aftermath of Dobbs. By hindering clinical research, these new obstacles will exacerbate existing health disparities experienced by these populations, which have historically been excluded from or exploited by the American healthcare and research systems.\nThis Article provides an in-depth legal analysis of the anti-abortion movement's new post-Dobbs strategies and how they may fetter clinical research that provides essential knowledge about the effects of medical products on pregnant persons and fetuses. Critically, this Article makes clear that Dobbs was not the anti-abortion movement's endgame. On the contrary, the anti-abortion movement has continued to mobilize post-Dobbs in pursuit of new legal strategies, including attacking the federal approval of mifepristone, reinvigorating the Comstock Act, and establishing fetal-personhood laws. In the context of clinical research, these post-Dobbs strategies will not only dilute medical knowledge and undermine scientific integrity they will also disproportionately affect populations already afflicted by glaring health disparities. After cataloging the various ways in which the anti-abortion movement's strategies will destabilize clinical research, this Article concludes with strategies to combat these pernicious results. Importantly, although this Article focuses on clinical research, it illustrates a broader consequence of the anti-abortion movement's new strategies: the aggravation of sex, gender, and racial disparities, which must be responded to with comprehensive counterstrategies

eYLS (Yale Law School)
Gender equality
Openalex Percentile: Top 39%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<i>Dobbs</i> and the Destabilization of Clinical Trials · eYLS (Yale Law School) (2024) | TGRS Research Map | TGRS